RESEARCH FINDINGS USING GUIDED IMAGERY FOR
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), sometimes called spastic colon, irritable colon, or nervous stomach, is a functional disorder of the bowel. It is marked by abdominal pain, and associated with changes in bowel habit (either in frequency, urgency, or characteristics). A precise cause is unknown, but faulty interaction between the gut, brain, and central nervous system seems to result in the bowel becoming over-reactive (Characteristics of IBS, 2006).
Additionally, the pain receptors in many IBS patients’ guts are unusually sensitive (Irritable Bowel Syndrome, 2006). Stress and diet don’t cause IBS, but they can trigger symptoms.
Many people develop IBS after a bacterial infection in the intestinal tract (gastroenteritis). This condition is referred to as post-infectious IBS. As many as 78% of people with IBS have an overgrowth of intestinal bacterial (Pimentel, Chow, and Lin, 2000).
The major symptom of IBS is a change in the patient’s bowel function -- usually diarrhea, constipation, or alternating between the two. Other symptoms include bloating, abdominal fullness, flatulence, nausea, and reflux (where stomach contents “back up”). Some people experience exhaustion or chest pain that is not cardiac--related. Depression is prevalent in IBS patients.
People with IBS often have a lower quality of life. IBS can affect sleep, sexual functioning, business and personal obligations, and social life. IBS is further complicated by comorbidity with other conditions, such as fibromyalgia, Chronic Fatigue Syndrome (CFIDS), and thyroid disease.
Incidence and Costs
IBS is more common than diabetes, asthma, heart disease, or hypertension (Adams and Benson, 1991). It affects between 20%-22% of Americans, 60%-65% of whom are women (Characteristics of IBS). Up to 70% of those meeting the diagnostic criteria for IBS do not seek treatment (Irritable Bowel Syndrome, 2002). Annual U.S. direct medical costs are estimated at $1.35 billion annually (Inadomi, Fennerty & Bjorkman, 2003), with 3.5 million office visits and 2.2 million prescriptions filled (Sandler, 1990).
Indirect costs, amounting to $205 million, include frequent absenteeism (Inadomi, Fennerty & Bjorkman). One study estimated that IBS patients are absent from work or school three times more often than their non-IBS counterparts (Drossman, Li, et al, 1993). Authors of another study concluded that 25% of those with IBS worked fewer hours, and 20% changed their work schedule because of the condition (Hungin, Tack, 2002).
Diagnosis and Medical Treatment
Since there are no conclusive diagnostic tests, IBS is a diagnosis of exclusion. This means that the doctors usually rule out other possible causes of the symptoms. Medication is geared toward reducing or relieving symptoms. Prescriptives include antispasmodics, antidiarrhetics, laxatives, bulking agents, and prokinetic agents (to move food quickly through the bowel). If a patient is depressed or has severe pain that doesn’t respond to other treatment, two other classes of drugs (SSRIs and low-dose tricyclic antidepressants) are used.
Early studies indicate that peppermint oil and Chinese herbal medicine warrant further study (Jailwala, Imperiale, and Kroenke, 2000), as do Slippery elm, fenugreek, devil's claw, tormentil and wei tong ning (Langmead, Dawson, et al, 2002). The results of one well-designed trial demonstrated that Chinese herbal medicine was significantly effective in improving symptoms, and quality of life (Bensoussan, Talley, et al, 1998).
Other non-pharmaceutical treatment includes patient education, diet modification (including identification and avoidance of food triggers), and mind-body therapies.
There is a strong mind-body component to IBS, and emotions have been shown to affect gut motility (Salt and Neimark, 2002; Whorwell, Houghton, et al, 1991) and patient perception, as illustrated in the study where hypnotically induced anger and excitement increased the motility of the colon, while happiness reduced motility (Houghton, Calvert, et al, 2002).
The literature supporting mind-body therapies is compelling. Relaxation (Blanchard, Greene, and Scharff, 1993; Keefer and Blanchard, 2001, 2002; Voirol and Hipolito, et al, 1987) and biofeedback (Leahy, Clayman, et al, 1998) have shown success in improving symptoms and preventing relapse. One approach (relaxation, therapy, and medication) was effective in two-thirds of patients who had not responded to medication alone (Guthrie, Creed et al, 1992).
Another combination regimen (progressive muscle relaxation, thermal biofeedback, cognitive therapy, education) had a 50% success rate, maintained four years later (Schwarz, Taylor, et al, 1990). Meditation was able to affect improvements that were maintained a year later (Keefer and Blanchard, 2002).
Confirming the power of the mind-body connection, placebo, positive suggestion, and positive expectation were effective in reducing both the sensory and motor components of the gastric response in IBS patients (Simren, Ringstrom, et al, 2004). Placebo and positive suggestion increased the effectiveness of lidocaine in reducing pain (Vase, Robinson, et al, 2003).
Recent reviews of the literature confirmed the efficacy of hypnosis (Hussain and Quigley, 2006; Tan, Hammond, and Joseph, 2005; Whitehead, 2006). Hypnosis uses relaxation, suggestion, and imagery for its effects (Palsson, undated). Its positive effects may be due to changes in colorectal sensitivity and improved psychological factors (Simren, 2006).
Hypnosis has been shown to improve symptoms (Palsson, Turner, et al, 2002), even in severe refractory cases (Barabasz A, Barabasz M, 2006; Forbes, MacAulay, and Chiotakakou-Faliakou, 2000; Francis and Houghton, 1996; Galovski and Blanchard, 1998; Houghton, Heyman, and Whorwell, 1996; Roberts, Wilson, et al, 2006), and in cases where psychotherapy has failed (Whorwell, Prior, and Faragher, 1984). Improvements can be sustained at long-term (Gonsalkorale, Miller, et al, 2003; Gonsalkorale & Whorwell, 2005).
Both the Forbes et al. and the Galovsky et al. studies used gut-directed suggestion, and the results showed significant symptom improvement. Forbes specifically looked at the effect of therapeutic suggestions on audiotape and found them effective. The Houghton et al. study results showed “profound” improvement in physical symptoms (pain bloating and bowel habit). People also felt that their quality of life was better, and that they felt more in control of their situation. They lost less time at work and needed fewer doctor’s office visits than the control group (Houghton, Heyman & Whorwell).
Researchers of one review paper reported that, in 19 of 22 studies reviewed, psychotherapy was superior to medication (Svedlund, 2002). In another study, patients receiving therapy improved, while patients receiving medication deteriorated (Svedlund, Sjodin, et al, 1983). A large-scale British study (250 patients) confirmed that hypnosis significantly improved not only symptoms, but also depression, anxiety, and quality of life (Gonsalkorale, Houghton, & Whorwell, 2002).
An at-home pre-scripted hypnosis was also effective, but not as effective as one-on-one hypnosis (Palsson, Turner, & Whitehead, 2006). Both individual and group hypnosis sessions proved effective (Harvey, Hinton, et al, 1989).
Mind-body techniques are effective in not only reducing IBS’s physical symptoms, but also in lifting depression and/or improving quality of life (Blanchard, Radnitz, et al, 1987; Gonsasalkorale, Toner, & Whorwell, 2004; Houghton Heyman & Whorwell, 1996; Read, 1999).
A very low-cost guided imagery program can improve patients’ abilities to cope with IBS pain, reduce or eliminate its symptoms and/or recurrences, reduce office visits, absenteeism and, in some cases, medications. These benefits can be long-lasting. It may improve patients’ quality of life and symptoms, even in difficult IBS cases.
Adams PF, Benson V. Current estimates from the National Health Interview Survey, 1990. Vital Health Stat 10. 1991 Dec(181):1-212.
Barabasz A, Barabasz M. Effects of tailored and manualized hypnotic inductions for complicated irritable bowel syndrome patients. International Journal of Clinical and Experimental Hypnosis. 2006 Jan; 54 (1):100-12.
Bensoussan A., Talley NJ, Hing M, Menzies R., Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11;280(18):1585-9.
Blanchard EB, Greene B, Scharff L, Schwarz-McMorris SP. Relaxation training as a treatment for irritable bowel syndrome. Biofeedback and Self Regulation. 1993 Sep, 18(3):125-32.
Blanchard EB, Radnitz C., Schwarz SP, Neff DF, Gerardi MA. Psychological changes associated with self-regularoty treatments of irritable bowel syndrome. Biofeedback Self Regul. 1987, Mar;12(1):31-7.
Characteristics of IBS. International Foundation for Functional Gastrointestinal Disorders, Inc. Last updated June 30, 2006.
Accessed August, 2006.
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. et al. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 38:1569-1580.
Forbes A, MacAulay, S, Chiotakakou-Faliakou, E. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome? Int. J. Colorectal Dis. 2000 Nov:15(5-6):328-34.
Francis CY, Houghton LA. Use of hypnotherapy in gastrointestinal disorders. European Journal of Gastroenterology and Hepatology. 1996 Jun, 8(6):525-9.
Forbes A, MacAulay S, Chiotakakou-Faliakou E. Hypnotherapy and therapeutic audiotape: effective in previously unsuccessfully treated irritable bowel syndrome? Int. J. Colorectal Dis. 2000 Nov:15(5-6):328-34.
Galovski TE, Blanchard EB. Treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback. 1998 Dec;23(4):219-32.
Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in Irritable Bowel Syndrome: A Large Scale Audit of a Clinical Service With Examination of Factors Influencing Responsiveness, Am J Gastroenterology 2002 94 954-961.
Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003 Nov; 52 (11): 1623-9.
Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res. 2004 Mar;56(3):271-8.
Gonsalkorale WM, Whorwell PJ.Hypnotherapy in the treatment of irritable bowel syndrome. European Journal of Gastroenterology and Hepatology. 2005 Jan; 17 (1):15-20.
Guthrie E, Creed F, Dawson D, Tomenson B. A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. British Journal of Psychiatry. 1993 Sep, 163:315-21.
Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet. 1989 Feb 25;1(8635):424-5.
Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut. 2002 Nov;51(5):701-4.
Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy. Alimentary Pharmacology and Therapeutics. 1996 Feb, 10(1):91-5.
Hungin APS, Tack J, Mearin F. Whorwell PJ, Dennis E, Barghoui V. Irritable Bowel Syndrome (IBS): prevalence and impact in the USA – the truth in IBS (T-IBS) survey. Am J Gastroenterol. 2002; 97:242.
Reported in Talley NJ. New and Important Insights Into IBS: From Epidemiology to Treatment.
Accessed August, 2006.
Hussain Z, Quigley EM. Systematic review: Complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther. 2006; 23(4):465-71.
Inadomi JM, Fennerty MB, Bjorkman D. The Economic Impact of Irritable Bowel Syndrome. Alimentary Pharacology & Therapeutics. 2003 Oct 1;18(7):671-82.
Irritable Bowel Syndrome. National Digestive Diseases Information Clearing House. NIH Publication No. 06–693 February 2006.
Accessed August, 2006
Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Ann Intern Med. 2000 133:136-147.
Keefer L, Blanchard, EB. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study. Behav Res Ther. 2001 Jul;39(7):801-11.
Keefer L, Blanchard EB. A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome. Behav Res Ther. 2002 May;40(5):541-6.
Langmead L, Dawson C, Hawkins C, Banna N, Loo S, Rampton DS. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther. 2002 Feb;16(2):197-205.
Leahy A, Clayman C, Mason I, Lloyd G, Epstein O. Computerized biofeedback games: a new method for teaching stress management and its use in irritable bowel syndrome. J R Coll Physicians Lond. 1997. Nov-Dec;32(6) :552-6.
Palsson OS. The Effects of Hypnosis On Gastrointestinal Problems. University of North Carolina – Chapel Hill, Department of Medicines. [undated]
http://www.med.unc.edu/medicine/fgidc/effects_of_hypnosis_on_gi_problems.pdf Accessed August, 2006.
Palsson OS, Turner MJ, Whitehead WE. Hypnosis home treatment for irritable bowel syndrome: a pilot study. International Journal of Clinical and Experimental Hypnosis. 2006 Jan; 54 (1):85-99.
Palsson OS, Turner MJ, Johnson DA, Burnelt CK, Whitehead WE. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci. 2002 Nov; 47(11):2605-14.
Pimentel M, Chow EJ, Lin HC, Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenerology. 2000 Dec;95(12):3503-6.
Read NW. Harnessing the patient’s powers of recovery: the role of the psychotherapies in the irritable bowel syndrome. Baillieres Best Pract Res Clin Gastroenterol. 1999, Oct;13(3):473-87.
Roberts L, Wilson S, Singh S, Roalfe A. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. British Journal of General Practice. 2006 Feb; 56 (523):115-21.
Salt WB, Neimark NF. Irritable Bowel Syndrome and the MindBodySpirit Connection. Parkview Publishing: Columbus, 2002.
Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990 99:409-415.
Schwarz SP, Blanchard EB, Berreman CF, Scharff L, Taylor AE, Greene BR, Suls JM, Malamood HS. Psychological aspects of irritable bowel syndrome: comparisons with inflammatory bowel disease and nonpatient controls. Behaviour Research and Therapy. 1993 Mar, 31(3):297-304.
Simren M. Hypnosis for irritable bowel syndrome: the quest for the mechanism of action. International Journal of Clinical and Experimental Hypnosis. 2006 Jan; 54 (1):65-84.
Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med. 2004 Mar-Apr;66(2):233-8.
Svedlund, J. Functional gastrointestinal diseases. Psychotherapy is an efficient complement to drug therapy. Lakartidningen. 2002 Jan 17;99(3):172-4.
Svedlund J, Sjodin I, Otosson JO, Dotevall, G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet. 1983, Sept 10;2(8350):589-92.
Tan G, Hammond DC, Joseph G. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action. Am J Clin Hypn. 2005 Jan;47(3):161-78.
Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain. 2003 Sep;105(1-2):17-25.
Voirol MW, Hipolito J. Anthropo-analytical relaxation in irritable bowel syndrome: results 40 months later. Schweiz Med Wochenschr. 1987 Jul 18;117(29):1117-9.
Whitehead WE. Hypnosis for irritable bowel syndrome: the empirical evidence of therapeutic effects. International Journal of Clinical and Experimental Hypnosis. 2006 Jan; 54 (1):7-20.
Whorwell PJ, Houghton LA, Taylor EE, Maxton DG. Physiological effects of emotion: assessment via hypnosis. Lancet. 1991 Aug 15;340(8816):434.
Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet. 1984 Dec 1;2(8414):1232-4.